Owner F. Hoffmann-La Roche AG

Inventors Chen, Li; He, Yun; Wong, Jason Christopher

Agent Davies Collison Cave

Pub. Number AU-A-2009210176

PCT Pub. Number WO2009/095324

Priority 08150805.3 29.01.08 EP

Filing date 19 January 2009

Wipo publication date 6 August 2009

C07C 237/20 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/255 (2006.01)

A61K 31/27 (2006.01)

A61K 31/275 (2006.01) - Nitriles

A61K 31/4453 (2006.01) - only substituted in position 1, e.g. propipocaine, diperodon

A61K 31/541 (2006.01) - Non-condensed thiazines containing further heterocyclic rings

A61P 35/02 (2006.01) Antineoplastic agents

C07C 255/60 (2006.01) Carboxylic acid nitriles

C07C 271/28 (2006.01) Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups

C07C 309/66 (2006.01) Sulfonic acids

C07D 213/75 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 295/13 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group